Volume 7, Issue 5
Article number e97218
Lysophospholipids--pharmacology; Muscular Dystrophy; Duchenne--drug therapy; Muscular Dystrophy; Duchenne--metabolism; Receptors; Lysosphingolipid--metabolism; STAT3 Transcription Factor--metabolism; Satellite Cells; Skeletal Muscle--drug effects; Satellite Cells; Skeletal Muscle--metabolism; Sphingosine--analogts & derivatives
Creative Commons License
The person who associated a work with this deed has dedicated the work to the public domain by waiving all of his or her rights to the work worldwide under copyright law, including all related and neighboring rights, to the extent allowed by law.
Loh, K.C., Leong, W., Carlson, M.E., Oskouian, B., Kumar, A., Fyrst, H., Zhang, M., Proia, R.L., Hoffman, E.P., Saba, J.D. (2012). Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS ONE, 7(5):e97218.